The resulting «map» of gene - drug interactions allowed the researchers to accurately predict the responses of
multiple human cancer cell lines to different chemotherapy agents based on the cell lines» genetic profiles and also revealed new genetic factors that appear to determine the response of breast and ovarian tumor cells to common classes of chemotherapy treatment.
Not exact matches
This study, which will be published Oct. 24 in eLife, and two other new Northwestern studies in Oncotarget and
Cell Cycle by the Peter group, describe the discovery of the assassin molecules present in
multiple human genes and their powerful effect on
cancer in mice.
Multiple effects of a novel epothilone analog on cellular processes and signaling pathways regulated by Rac1 GTPase in the
human breast
cancer cells.
As in
human medicine,
multiple treatments are required to kill the
cancer cells while minimizing damage to surrounding normal tissues.